Urologists and clinical trials
Cora N Sternberg
This article has no abstract so we have provided the first paragraph of the full text.
There is no doubt that patients with genitourinary malignancies receive the best care when they are assessed and treated by a multidisciplinary, collaborating team of specialists; however, with regards to putting patients with urologic malignancies into clinical trials, this type of cooperation is often substantially lacking.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.